University of California - Los Angeles — Los Angeles, California

Public research footprint of University of California - Los Angeles, compiled from the ClinicalTrials.gov public registry.

1,324

Registered studies

450

Active

257

Recruiting now

632

Completed

191

Stopped or withdrawn

Most-studied conditions

Amyotrophic Lateral Sclerosis · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Early Parkinson Disease (Early PD) · Diffuse Large B-cell Lymphoma

Recently updated registry entries

NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)
NCT06873581 — Pivotal Study of Voro Urologic Scaffold (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California - Los Angeles?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.